Clinical Trials · NCT00796458
Androgen Ablation With or Without Docetaxel in Treating Patients With Advanced Prostate Cancer
- Phase
- Phase 3
- Recruitment status
- Unknown
- Sponsor
- A.O.U. San Giovanni Battista di Torino, Italy
- Enrollment
- 200
- Start date
- Apr 2005
- Locations
- 1 site, Italy
- Primary endpoint
- 2-year progression-free survival rate